393 related articles for article (PubMed ID: 27075079)
1. Cancer therapy: an evolved approach.
Willyard C
Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079
[No Abstract] [Full Text] [Related]
2. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
3. Cancer and natural selection.
Fillon M
J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180
[No Abstract] [Full Text] [Related]
4. Calculated resistance in cancer.
Sawyers CL
Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
[No Abstract] [Full Text] [Related]
5. Combining targeted drugs to stop resistant tumors.
Kaiser J
Science; 2011 Mar; 331(6024):1542-5. PubMed ID: 21436437
[No Abstract] [Full Text] [Related]
6. HDAC inhibitors with PD-1 blockade: a promising strategy for treatment of multiple cancer types?
Beg AA; Gray JE
Epigenomics; 2016 Aug; 8(8):1015-7. PubMed ID: 27410519
[No Abstract] [Full Text] [Related]
7. Drug Resistance in Hematological Malignancies.
Auberger P; Tamburini-Bonnefoy J; Puissant A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847013
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation-Targeted Drugs.
Da Costa EM; McInnes G; Beaudry A; Raynal NJ
Cancer J; 2017; 23(5):270-276. PubMed ID: 28926427
[TBL] [Abstract][Full Text] [Related]
9. T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting.
Hanley CJ; Thomas GJ
Br J Cancer; 2020 Oct; 123(9):1353-1355. PubMed ID: 32830198
[TBL] [Abstract][Full Text] [Related]
10. New research shows why advanced cancers recur after targeted treatments.
Printz C
Cancer; 2012 Oct; 118(20):4913. PubMed ID: 23042616
[No Abstract] [Full Text] [Related]
11. Finding the tumor copycat. Therapy fails, patients don't.
Ellis LM; Fidler IJ
Nat Med; 2010 Sep; 16(9):974-5. PubMed ID: 20823880
[No Abstract] [Full Text] [Related]
12. Metastasis treatment strategies.
Mali S
J Craniofac Surg; 2014 Sep; 25(5):1590-2. PubMed ID: 25203565
[No Abstract] [Full Text] [Related]
13. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
Gillet JP; Gottesman MM
Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
[No Abstract] [Full Text] [Related]
14. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
15. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer: diagnostic, biological and prognostic aspects.
Davidson B; Tropé CG
Womens Health (Lond); 2014 Sep; 10(5):519-33. PubMed ID: 25335543
[TBL] [Abstract][Full Text] [Related]
17. Myeloma researchers gain genome, new targets, and new concerns.
Brower V
J Natl Cancer Inst; 2011 Jul; 103(14):1082-5. PubMed ID: 21737696
[No Abstract] [Full Text] [Related]
18. NCI-MATCH launch highlights new trial design in precision-medicine era.
McNeil C
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
[No Abstract] [Full Text] [Related]
19. Metastasis awakening: the challenges of targeting minimal residual cancer.
Polzer B; Klein CA
Nat Med; 2013 Mar; 19(3):274-5. PubMed ID: 23467237
[No Abstract] [Full Text] [Related]
20. Strategies for individualizing management of patients with metastatic melanoma: a managed care perspective.
Goldstein DA; Zeichner SB
Am J Manag Care; 2015 Sep; 21(10 Suppl):S234-41. PubMed ID: 26619297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]